RecallReported September 30, 2026
Class II recall by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dr…
FDA's enforcement report of September 30, 2026 lists a Class II recall by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company of Tarrytown, NY. Product: Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dr…. Status: Ongoing.
On the record
- Recalling firm
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
- Location
- Tarrytown, NY
- Classification
- Class II
- Status
- Ongoing
- Recall number
- D-0870-2026
- Product type
- Drugs
- Recall initiated
- 2026-09-15
- Reported by FDA
- 2026-09-30
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.